Register Login

Bicycle Therapeutics (BCYC)

Swanton Robert Charles 🟢 acquired 11.2K shares (1 derivative) of BICYCLE THERAPEUTICS PLC (BCYC) at $7.08 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot Jan. 7, 2026, 1:23 a.m.

    🔍 Swanton Robert Charles (Executive)

    Company: BICYCLE THERAPEUTICS PLC (BCYC)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 11,179

    Detailed Transactions and Holdings:

    • Acquired 3,726 shares of Ordinary Shares (Direct)
      Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 19,213.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 7,453 shares of Stock Option (right to buy) at $7.08 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 7,453.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.
    • F2: Each RSU represents a contingent right to receive one ordinary share.
    • F3: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

Search

News categories